Koppel GA[au] - Search Results

Year	Number of Results
1972	1
1973	2
1976	2
1977	1
1981	1
1983	1
1990	1
1992	1
1993	1
1996	2
1998	1
2006	1
2007	1
2008	1
2009	1
2023	0

1

Vasopressin antagonists as anxiolytics and antidepressants: recent developments.

Simon NG, Guillon C, Fabio K, Heindel ND, Lu SF, Miller M, Ferris CF, Brownstein MJ, Garripa C, Koppel GA. Simon NG, et al. Among authors: koppel ga. Recent Pat CNS Drug Discov. 2008 Jun;3(2):77-93. doi: 10.2174/157488908784534586. Recent Pat CNS Drug Discov. 2008. PMID: 18537767 Review.

2

Azetidinones as vasopressin V1a antagonists.

Guillon CD, Koppel GA, Brownstein MJ, Chaney MO, Ferris CF, Lu SF, Fabio KM, Miller MJ, Heindel ND, Hunden DC, Cooper RD, Kaldor SW, Skelton JJ, Dressman BA, Clay MP, Steinberg MI, Bruns RF, Simon NG. Guillon CD, et al. Among authors: koppel ga. Bioorg Med Chem. 2007 Mar 1;15(5):2054-80. doi: 10.1016/j.bmc.2006.12.031. Epub 2006 Dec 23. Bioorg Med Chem. 2007. PMID: 17234419 Free PMC article.

3

Schultz-Dale reaction in mouse trachea.

Koppel GA, Haisch KD, Spaethe SM, Schmidtke JR, Fleisch JH. Koppel GA, et al. J Pharmacol Methods. 1981 Aug;6(1):39-43. doi: 10.1016/0160-5402(81)90082-6. J Pharmacol Methods. 1981. PMID: 7265992

4

Recent advances with monoclonal antibody drug targeting for the treatment of human cancer.

Koppel GA. Koppel GA. Bioconjug Chem. 1990 Jan-Feb;1(1):13-23. doi: 10.1021/bc00001a002. Bioconjug Chem. 1990. PMID: 2095201 Review. No abstract available.

5

A novel class of 5-HT2A receptor antagonists: aryl aminoguanidines.

Bryant HU, Nelson DL, Button D, Cole HW, Baez MB, Lucaites VL, Wainscott DB, Whitesitt C, Reel J, Simon R, Koppel GA. Bryant HU, et al. Among authors: koppel ga. Life Sci. 1996;59(15):1259-68. doi: 10.1016/0024-3205(96)00449-3. Life Sci. 1996. PMID: 8845011

6

Clavulanic acid: a competitive inhibitor of beta-lactamases with novel anxiolytic-like activity and minimal side effects.

Kim DJ, King JA, Zuccarelli L, Ferris CF, Koppel GA, Snowdon CT, Ahn CH. Kim DJ, et al. Among authors: koppel ga. Pharmacol Biochem Behav. 2009 Aug;93(2):112-20. doi: 10.1016/j.pbb.2009.04.013. Epub 2009 Apr 24. Pharmacol Biochem Behav. 2009. PMID: 19394358

7

LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.

Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, Koppel GA, Brownstein M. Felder CC, et al. Among authors: koppel ga. J Pharmacol Exp Ther. 1998 Jan;284(1):291-7. J Pharmacol Exp Ther. 1998. PMID: 9435190

8

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM, Becker GW. Felder CC, et al. Among authors: koppel ga. FEBS Lett. 1996 Sep 16;393(2-3):231-5. doi: 10.1016/0014-5793(96)00891-5. FEBS Lett. 1996. PMID: 8814296 Free article.

9

The conversion of 3-exo-methylencephalosporin to 3-halomethylcephems; a convenient synthesis of 3'-substituted cephalosporins from penicillins.

Koppel GA, Kinnick MD, Nummy LJ. Koppel GA, et al. J Am Chem Soc. 1977 Apr 13;99(8):2822-3. doi: 10.1021/ja00450a081. J Am Chem Soc. 1977. PMID: 850040 No abstract available.

10

Substrate inhibition of beta-lactamases, a method for predicting enzymatic stability of cephalosporins.

Mahoney DF, Koppel GA, Turner JR. Mahoney DF, et al. Among authors: koppel ga. Antimicrob Agents Chemother. 1976 Sep;10(3):470-5. doi: 10.1128/AAC.10.3.470. Antimicrob Agents Chemother. 1976. PMID: 984790 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results